MLN8237, an oral selective Aurora A kinase inhibitor: initial results of dose-finding pharmacokinetic-pharmacodynamic phase I study

1. Tabernero-Caturla, J.
2. Cervantes, A.
3. Elez, E.
4. Macarulla, T.
5. Rosello, S.
6. Rodriguez-Braun, E.
7. Stringer, B.
8. Shinde, V.
9. Danaee, H.
10. Eton, O.